The WARF Gilson Discovery Series presents “Faculty Entrepreneurship” with Thomas Rockwell Mackie, co-founder, Chairman of the Board and Director of Research at TomoTherapy, on Wednesday, April 2. The event at the Fluno Center for Executive Education, 601 University Avenue, includes a presentation and discussion at 5 p.m. followed by a reception at 6 p.m.
Companies are often born when research endeavors meet a market need. Seventeen years ago, UW-Madison scientists Rock Mackie and Paul Reckwerdt identified a need for improved image guidance in radiation treatment for cancer. Today, as a result of their High-Art slice therapy system, TomoTherapy has multiple issued and pending patents, as well as exclusive licenses on more than 100 issued and pending patents worldwide. The company completed its initial public offering in May 2007, the largest in Wisconsin history. Headquartered in Madison, TomoTherapy has European operations in Belgium
and more than 150 installations in 16 countries around the world. Dr. Mackie will speak on the importance and challenges of faculty entrepreneurship, drawing from his extensive research and business experiences.
The Gilson Series is hosted by the Wisconsin Alumni Research Foundation, with funding provided by a gift from the late Dr. Warren Gilson.